Figure 4From: Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study Change from baseline in 24-hour mean glucose by CGM based on analyses of covariance in the full analysis set. CGM, continuous glucose monitoring; CI, confidence interval; SE, standard error.Back to article page